Larvol Delta - Suppression-of-KRAS-and-CBL-mutations-and-hematological-improvement-by-Lenzilumab-and-Azacitidine-treatment-in-proliferative-chronic-myelomonocytic-leukemia

cyclophosphamide - Generic mfg.

Yescarta (axicabtagene ciloleucel) - Gilead

LENZ (lenzilumab) - Humanigen

fludarabine IV - Generic mfg.

http://clinicaltrials.gov/ct2/show/NCT04314843

Mar 4, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next